ArticleJournal of personalized medicine2021

The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone.

Yan-Rong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.